Frequency of Stroke Patients Qualified for Recombinant Tissue Plasminogen Activator (R-Tpa) and Constraints in Zahedan 2016
International Journal of Basic & Clinical Pharmacology
doi 10.18203/2319-2003.ijbcp20175670
Full Text
Open PDFAbstract
Available in full text
Date
December 23, 2017
Authors
Publisher
Medip Academy